Past Newsletters

The Drug Hunter e-mail newsletter was launched in Oct. 2020 and has grown to >5,000 subscribers in less than a year. Below are links to examples of our e-mail newsletters that were published in the past. Consider subscribing to get content, free downloadable PDFs, upcoming events, and career highlights directly to your inbox. You can unsubscribe anytime.

Last Updated : February 15, 2024

#168-Wed. Feb. 14, 2024 -Molecules Of The Month Jan. 24 - Feb. 24 Week 1

#167-Wed. Feb. 7, 2024-Content Roundup - Feb. 24 Week 1

#166-Wed. Jan. 31, 2024- Content Roundup - Jan. 24 Week 4

#165-Wed. Jan. 24, 2024 - Large Molecule Approvals, KRAS Roundup Part II - Jan. 24 Week 3

#164-Wed. Jan. 18, 2024 - Molecules of the Month December 2023

#163-Tue. Jan. 16, 2024 - 2023 Small Molecule Drug Approvals

#162-Wed. Jan. 10, 2024 -Content Roundup - Jan. 24 Week 2

#161-Wed. Dec. 27, 2023 - Content Roundup - Dec. 23 Week 4

#160-Wed. Dec. 20, 2023 - Content Roundup - Dec. 23 Week 3

#159-Wed. Dec. 13, 2023 - Molecules Of The Month Nov 23 - Dec. 23 Week 2

#158-Wed. Dec. 06, 2023 - Content Roundup - Dec. 23 ( Sponsor: Hypha)

#157-Thurs. Nov. 30 2023 - Content Roundup - Nov. 23 Week 4

#156-Mon. Nov. 20 2023 - Monday Molecules - Compound Collection Highlight

#155-Mon. Nov. 13 2023 - Molecules Of The Month - October 2023 (Sponsor: CCDC)

#154-Fri. Nov. 03 2023 - KRAS Roundup And GLP-1 Review

#153-Sun. Oct. 29, 2023 - Sunday Small Molecules

#152-Sun. Oct. 22, 2023 - vorasidenib (AG-881)

#151-Tues. Oct. 17, 2023 - Molecules Of The Month – September 2023 (Sponsor: Oncodesign Services)

#150-Tues. Oct. 11, 2023 - BTK And ETAR (Sponsor: Malvern)

#148-Fri. Oct. 05, 2023 - Phase III Is Coming

#147-Thurs. Sep. 28, 2023  - Imidazole Metabolism Spotlight (Sponsor: Hypha)

#146-Thurs. Sep. 21, 2023 – Recent Synthesis Highlights From MOTM (Sponsor: Sinocompound)

#145-Tue. Sep. 19, 2023 – Molecules Of The Month – August 2023 (Sponsor: Oncodesign Services)

#144-Wed. Sep. 6, 2023 – Methods For Identifying Ligand Binding Sites In Drug Discovery (Sponsor: Crystals First)

#143-Tue. Aug. 29, 2023 – How To Get Drugs Into The Brain (Sponsor: Oncodesign Services)

#142-Sat. Aug. 19, 2023 – ACS First Disclosures ’23 – 8-21-23 (Sponsor: Crystals First)

#141-Wed. Aug. 9, 2023 – Molecules Of The Month – July 2023 (Sponsor: Nuchem Sciences)

#140-Fri. Jul. 27, 2023 – Sponsored – Ten Ways Degraders Differentiate From Traditional Small Molecules (Sponsor: Revvity Signals)

#139-Mon. Jul. 17, 2023 – 07-17 Round- Up (Sponsor: Revvity Signals)

#138-Thurs. Jun. 27, 2023 – Patent Highlights And Molecules On The Move (Sponsor: Bio-Techne)

#137-Thurs. Jun. 15, 2023 – Molecules Of The Month – May 2023 (Sponsor: Bio-Techne)

#136-Mon. Jun. 12, 2023 –Small Molecules Evolve (Sponsor: Biotechnology Innovation Organization)

#135-Tues. Jun. 6, 2023 – Ring-Closing Metathesis – (Sponsor: Sinocompound)

#134-Thurs. Jun. 1, 2023 – Molecules On The Move – Apr 2023

#133-Mon. May. 22, 2023 – Degrader Radar – April – 2023 (Sponsor: Crystals First)

#132-Fri. May. 12, 2023 – Molecules Of The Month – April 2023 (Sponsor: Biognosys)

#131-Mon. May. 1, 2023 – Target Identification Methods (Sponsor: Pelago Bioscience)

#130-Sun. Apr. 23, 2023 – Journal Club – March 2023

#129-Fri. Apr. 21, 2023 – Small Molecule Of The Year – 2022 (Sponsor: Porton)

#128-Wed. Apr. 19, 2023 – March ’23 AACR Coverage (Sponsor: Hypha Discovery)

#127-Sun. Apr. 16, 2023 – March ’23 Molecules In Motion (Sponsor: Biognosys)

#126-Fri. Apr. 7, 2023 – Molecules Of The Month – March 2023 (Sponsor: CCDC)

#125-Fri. Apr. 2, 2023 – ACS First Disclosures IN 2023 (Sponsor: Biognosys)

#124-Fri. Mar. 24, 2023 – Molecules Of The Month – February 2023 (Sponsor: CCDC)

#123-Tue. Mar. 14, 2023 – 2022 Molecule Madness – Vote For The Molecule Of The Year! (Sponsor: Porton)

#122-Sun. Mar. 12, 2023 – Journal Club Newsletter

#121-Tue. Mar. 7, 2023 – Another KRASG12C Inhibitor In Ph. III, Bayer’s Massive FXIa Ph. III Clinical Trial, And 21 Other Molecules In The News

#120-Tue. Feb. 28, 2023 – Molecules Of The Month – January 2023 (Sponsor: Porton)

#119-Wed. Feb. 22, 2023 – A Potential Best-In-Class KRASG12C Inhibitor? Adagrasib

#118-Tue. Feb. 21, 2023 – Not Your Grandparents’ Drugs: How Approved Drugs Have Evolved Since The 70’S

#117-Fri. Feb. 10, 2023 – Small Molecules In The News – Jan

#116- Fri. Feb. 3, 2023 – 2022 Molecule Of The Year, Nominate!

#115- Tue. Jan. 31, 2023 – Molecules Of The Month – December 2022

#114- Sat. Jan. 28, 2023 – First-In-Class Large Molecule Drug Approvals Of 2022

#113- Tue. Jan. 24, 2023 – AI for All? How Pharma Partnerships Improve Software Solutions

#112- Fri. Jan. 20, 2023 – First-in-Class Small Molecule Drug Approvals of 2022

#111- Wed. Jan. 11, 2023 – January Articles

#110- Sat. Jan. 7, 2023 – 2022 Large Molecule Drug Approvals

#109- Sat. Dec. 31, 2022 – 2022 Novel Small Molecule Drug Approvals

#108- Fri. Dec. 30, 2022 – Molecules Of The Month – November 2022 (Sponsor: Porton)

#107- Tue. Dec. 27, 2022 – The Molecular Glue Degrader Landscape in 2022 (Sponsor: CAS)

#106- Fri. Dec. 16, 2022 – A Covalent KRASi from a Reversible Starting Point

#105- Sun. Dec. 11, 2022 – Why Did Bristol Myers Squibb (BMS) Pay $4.1 Billion for Another Kinase Inhibitor? (Sponsor: Hypha Discovery)

#104- Wed. Dec. 7, 2022 – Billion-Dollar Biotransformations: On the Metabolism of Ozanimod (Sponsor: Hypha Discovery)

#103- Wed. Nov. 30, 2022 – Molecules Of The Month – October 2022 A / B (Sponsor: Porton)

#102- Fri. Nov. 18, 2022 – Are Drugs Becoming More Lipophilic Over Time (Sponsor: Nanoform)? 

#101- Tue. Nov. 15, 2022 – PI3K Review (Sponsor: Oncodesign Services)

#100- Wed. Nov. 9, 2022 – AI Series A / B (Sponsor: OpenBench)

#99- Wed. Nov. 2, 2022 – Sinocompound Atropisomers A / B (Sponsor: Sinocompound)

#98- Sun. Oct. 30, 2022 – Molecules Of The Month – September 2022 A / B (Sponsor: Porton)

#97- Tues. Oct. 18, 2022 – August 2022 MOTM Runners Up

#96- Fri. Oct. 14, 2022 – Deucravacitinib Approval

#95- Fri. Oct. 7, 2022 – Voxelotor (GBT Aquisition)

#94- Mon. Oct. 3, 2022 – Computational Partnership In Small Molecule Drug Discovery (Sponsor: Schrodinger)

#93- Fri. Sep. 30, 2022 – Molecules Of The Month – Aug 2022 (Sponsor: Sinocompound)

#92- Tues. Sep. 27, 2022 – August Approvals + Drug Discovery Tech Reviews

#91- Sun. Sep. 25, 2022 – Billion-Dollar Molecules: Avacopan

#90- Sun. Sep. 18, 2022 – MOTM Runners (Sponsor: Pelago)

#89- Wed. Sep. 14, 2022 – First Disclosures From EFMC-ISMC Nice (Sponsor: Optibrium)

#88- Thurs. Sep. 8, 2022 – Phase II Metabolism Poster (Sponsor: Hypha Discovery)

#87- Wed. Aug. 31, 2022 – Molecule Spotlight: Risdiplam

#86- Sun. Aug. 28, 2022 – Molecules Of The Month – July 2022 (Sponsor: Pelago Bioscience)

#85- Thurs. Aug. 25, 2022 – First Disclosures from ACS Chicago

#84- Fri. Aug. 19, 2022 – What Makes a Drug Best-in-Class?

#83- Fri. Aug. 12, 2022 – Small Molecule and Biotechnology-Based Therapeutics for Neurology-Focused Companies: 2021’s IPOs Part V

#82- Fri. Aug. 5, 2022 – Molecules of the Month Runners-Up – June 2022

#81- Fri. Jul. 28, 2022 – Molecules Of The Month – June 2022 (Sponsor: Pelago Bioscience)

#80- Wed. Jul. 27, 2022 – Biotech IPOs 4

#79- Sun. Jul. 24, 2022 – Minimum Viable Experiments with Imperfect Molecules: a Minipump Minirevie (Sponsor: iPrecio)

#78- Tue. Jul. 19, 2022  Ten Moving Targets in 2022

#77- Sun. Jul. 17, 2022 – Why do pKas Matter in Medicinal Chemistry? (Sponsor: Analiza)

#76- Tue. Jul. 12, 2022 – FDA Novel Drug Approvals: June 2022

#75- Sun. Jul. 10, 2022 – Drug Hunters Reunited After 28 Years

#74- Sun. Jun. 26, 2022 – Introducing Molecules Of The Month Runners-Up

#73- Thurs. Jun. 23, 2022 – Shaken by an Unexpected Connection with a Patient

#72- Sun. Jun. 19, 2022 – Molecules of the Month – May 2022 (Sponsor: Nuchem Sciences)

#71- Thurs. Jun. 16, 2022 – NYC Event June 28

#70- Fri. Jun. 10, 2022 – Acceleron’s TGF-Beta Ligand Trap, Trillium’s SIRP-Alpha Fusion Proteins, And Eight Other Large Molecules Acquired In 2021

#69- Tues. Jun. 07, 2022 – Novel Drug Approvals – May 2022

#68- Fri. Jun. 03, 2022 – Drug Discovery IPO Trends In 2021

#67- Tues. May. 31, 2022 – What Is A Best In Class Drug?

#66- Wed. May. 18, 2022 – Molecules Of The Month – April 2022 (Sponsor: Nanoform)

#65- Fri. May. 13, 2022 – Small Molecule Long-Acting Injectables For HIV (A /B)

#64- Thurs. May. 12, 2022 – Fragment-Based Drug Discovery Minireview (A/B)

#63- Tues. May. 10, 2022 – Synthesis Spotlight – Dimethylcyclopropylproline On Production-Scale (Sponsor: BirdoTech)

#62- Sun. May. 7, 2022 – Mechanisms of Assay Interference: AICS and Pains (Sponsor: Nanoform)

#61- Wed. May. 04, 2022 – An Oral Myosin Inhibitor and CYP-Sparing Antifungal (Sponsor: Nanoform)

#60- Tues. May. 03, 2022 – Why Did GSK Pay $1.9B for Momelotinib, an Oral Ph. III Myelofibrosis Candidate? and Literature Review

#59- Fri. Apr. 29, 2022  SF Bay Area Meetup

#58- Thurs. Apr. 28, 2022 – Q1 2022 Webinar Recap Part 1 (A)

#57- Sun. Apr. 24, 2022 – 04-24-22 – Weekly – IND And MA (A/B)

#56- Wed. Apr. 20, 2022 – Molecules Of The Month – March 2022  (A/B)

#55- Mon. Apr. 18, 2022 – Solid Form Strategies For Increasing Oral Bioavailability (Sponsor: Nanoform)

#54- Wed. Apr. 13, 2022 – Letters from Drug Hunters #1 – Apr. 2022 (A/B

#53- Mon. Apr. 11, 2022 – AACR Spring 2022 Disclosures

#52- Thurs. Apr. 7, 2022 – FDA Novel Drug Approvals: March 2022

#51- Sun. Mar. 20, 2022 – 2021 Neurology Drug Approvals: Small Molecule Deep Dive

#50- Sun. Mar. 13, 2022 – Molecules Of The Month – Feb 2022  A/B (Sponsor: Porton)

#49- Thurs. Mar. 10, 2022 – Phase I Drug Metabolism Poster A/B (Sponsor: Hypha Discovery)

#48- Tues. Mar. 08, 2022 – 2021 Molecule Of The Year A/B (Sponsor: Pelago Bioscience)

#47- Sun. Feb. 27, 2022 – HIV Maturation Inhibitor, GSK3640254 A/B (Sponsor: Pelago Bioscience)

#46- Wed. Feb. 23, 2022 – 2021 Oncology FDA Approvals: Small Molecules Deep Dive (A/B)

#45- Thurs. Feb. 17, 2022 – 2021 Molecules of the Year Deep Dive (A/B)

#44- Wed. Feb. 16, 2022 – It’s Always Seems Impossible Until It’s Done

#43 – Tues. Feb. 15, 2022 – 2021 First-In-Class Small Molecule Drugs Deep Dive

#42 – Sun. Feb. 13, 2022 – Molecules of the Month – Jan. 2022 (A/B (Sponsor: Pelago Bioscience)

#41 – Wed. Feb. 9, 2022  Molecules of the Year

#40 – Sun. Feb. 6, 2022 – 2021 Large Molecule Drug Approvals Review – Pt. 2 (A/B)

#39 – Thurs. Feb. 3, 2022 – Advisory Board: Andrew Setikas

#38 – Tues. Feb. 1, 2022 – 2021 Large Molecule Drug Approvals Review (A/B)

#37 – Mon. Jan. 31, 2022 – Advisory Board: Gary Yeung, CFA

#36 – Wed. Jan. 26, 2022 – Advisory Board: Wendy Young, Ph. D.

#35 – Sun. Jan. 30, 2022 – 2021 Small Molecule Drug Approvals Review (A/B)

#34 – Wed. Jan. 26, 2022 – What is a Drug Hunter?

#33 – Sun. Jan. 23, 2022 – Molecules of the Month – Dec. 2021 (Sponsor: Hypha Discovery)

#32 – Sun. Jan. 9, 2022 – It Takes a Village 

#31 – Sun. Dec. 12, 2021 – Small Molecules of the Month – Nov. 2021

#30 – Sun. Nov. 14, 2021 – Small Molecules of the Month – Oct. 2021 (Sponsor: ChemSpace)

#29 – Sun. Oct. 31, 2021 – CD47-SIRPa Drug Target Minirevie (Sponsor: California Lifescience and Catalent Biologics)

#28 – Tue. Oct. 12, 2021 – Molecules of the Month – Sep. 2021 (Sponsor: Sciencex )

#27 – Sun. Sep. 26, 2021 – The Resurgence of Antibody-Drug Conjugates – FDA Approved ADCs (Sponsor: California Lifescience and Catalent Biologics)

#26 – Sat. Sep. 18, 2021 – Vote! Pantheon Award for Scientific Advancement

#25 – Sun. Sep. 12, 2021 – Molecules Of The Month – Aug. 2021 (Sponsor: GoStar)

#24 – Sun. Sep. 5, 2021 – First Disclosures of Small Molecule Drug Candidates – EFMC Conference – 2021

#23 – Tue. Aug. 31, 2021 – Science Highlights of 2020 IPOs (Sponsor: California Lifescience and Catalent Biologics)

#22 – Sun. Aug. 15, 2021 – Molecules Of The Month – Jul. 2021 (Sponsor: ACHEMBLOCK)

#21 – Sun. Aug. 1, 2021 – 2020 Biotech IPOs – Small Molecule R&D Companies (Sponsor: Sciex)

#20 – Sun. Jul. 25, 2021 – 2020 Biotech IPOs – Large Molecule R&D Companies (Sponsor: California and Catalent Biologics)

#19 – Sun. Jul. 18, 2021 – Molecules Of The Month – Jun. 2022 (Sponsor: Asha)

#18 – Sun. Jul. 11, 2021 – Small Molecule Immunomodulators – H1 2021

#17 – Tue. Jul. 6, 2021 – 2021 Pantheon Award for Scientific Advancement (Sponsor: California Sciences)

#16 – Sun. Jun. 20, 2021 – Molecules Of the Month – May 2021 (Sponsor: Sai)

#15 – Sun. Jun. 6, 2021 – 2020 Small Molecule Drug Approvals

#14 – Fri. May 14, 2021 – Molecules Of the Month – Apr. 2021

#13 – Sat. Apr. 24, 2021 – 2020 Large Molecule Drug Approvals

#12 – Sun. Apr. 18, 2021 – Molecules Of The Month – Mar. 2021